IBDEI30M ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,48152,1,3,0)
;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/o Macular Edema,Bilateral
;;^UTILITY(U,$J,358.3,48152,1,4,0)
;;=4^E11.3393
;;^UTILITY(U,$J,358.3,48152,2)
;;=^5138345
;;^UTILITY(U,$J,358.3,48153,0)
;;=E11.3411^^185^2417^43
;;^UTILITY(U,$J,358.3,48153,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48153,1,3,0)
;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Right Eye
;;^UTILITY(U,$J,358.3,48153,1,4,0)
;;=4^E11.3411
;;^UTILITY(U,$J,358.3,48153,2)
;;=^5138347
;;^UTILITY(U,$J,358.3,48154,0)
;;=E11.3412^^185^2417^44
;;^UTILITY(U,$J,358.3,48154,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48154,1,3,0)
;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Left Eye
;;^UTILITY(U,$J,358.3,48154,1,4,0)
;;=4^E11.3412
;;^UTILITY(U,$J,358.3,48154,2)
;;=^5138348
;;^UTILITY(U,$J,358.3,48155,0)
;;=E11.3413^^185^2417^45
;;^UTILITY(U,$J,358.3,48155,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48155,1,3,0)
;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Bilaterral
;;^UTILITY(U,$J,358.3,48155,1,4,0)
;;=4^E11.3413
;;^UTILITY(U,$J,358.3,48155,2)
;;=^5138349
;;^UTILITY(U,$J,358.3,48156,0)
;;=E11.3491^^185^2417^46
;;^UTILITY(U,$J,358.3,48156,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48156,1,3,0)
;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Right Eye
;;^UTILITY(U,$J,358.3,48156,1,4,0)
;;=4^E11.3491
;;^UTILITY(U,$J,358.3,48156,2)
;;=^5138351
;;^UTILITY(U,$J,358.3,48157,0)
;;=E11.3492^^185^2417^47
;;^UTILITY(U,$J,358.3,48157,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48157,1,3,0)
;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Left Eye
;;^UTILITY(U,$J,358.3,48157,1,4,0)
;;=4^E11.3492
;;^UTILITY(U,$J,358.3,48157,2)
;;=^5138352
;;^UTILITY(U,$J,358.3,48158,0)
;;=E11.3493^^185^2417^48
;;^UTILITY(U,$J,358.3,48158,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48158,1,3,0)
;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Bilateral
;;^UTILITY(U,$J,358.3,48158,1,4,0)
;;=4^E11.3493
;;^UTILITY(U,$J,358.3,48158,2)
;;=^5138353
;;^UTILITY(U,$J,358.3,48159,0)
;;=E11.3511^^185^2417^37
;;^UTILITY(U,$J,358.3,48159,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48159,1,3,0)
;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Right Eye
;;^UTILITY(U,$J,358.3,48159,1,4,0)
;;=4^E11.3511
;;^UTILITY(U,$J,358.3,48159,2)
;;=^5138355
;;^UTILITY(U,$J,358.3,48160,0)
;;=E11.3512^^185^2417^38
;;^UTILITY(U,$J,358.3,48160,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48160,1,3,0)
;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Left Eye
;;^UTILITY(U,$J,358.3,48160,1,4,0)
;;=4^E11.3512
;;^UTILITY(U,$J,358.3,48160,2)
;;=^5138356
;;^UTILITY(U,$J,358.3,48161,0)
;;=E11.3513^^185^2417^39
;;^UTILITY(U,$J,358.3,48161,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48161,1,3,0)
;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Bilateral
;;^UTILITY(U,$J,358.3,48161,1,4,0)
;;=4^E11.3513
;;^UTILITY(U,$J,358.3,48161,2)
;;=^5138357
;;^UTILITY(U,$J,358.3,48162,0)
;;=E11.3551^^185^2417^50
;;^UTILITY(U,$J,358.3,48162,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,48162,1,3,0)
;;=3^Diabetes Type 2 w/ Stable Prolif Rtnop,Right Eye
;;^UTILITY(U,$J,358.3,48162,1,4,0)
;;=4^E11.3551
;;^UTILITY(U,$J,358.3,48162,2)
;;=^5138371
;;^UTILITY(U,$J,358.3,48163,0)
;;=E11.3552^^185^2417^51
;;^UTILITY(U,$J,358.3,48163,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI30M 3767 printed Nov 22, 2024@17:49:38 Page 2
IBDEI30M ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,48152,1,3,0)
+2 ;;=3^Diabetes Type 2 w/ Mod Nonp Rtnop w/o Macular Edema,Bilateral
+3 ;;^UTILITY(U,$J,358.3,48152,1,4,0)
+4 ;;=4^E11.3393
+5 ;;^UTILITY(U,$J,358.3,48152,2)
+6 ;;=^5138345
+7 ;;^UTILITY(U,$J,358.3,48153,0)
+8 ;;=E11.3411^^185^2417^43
+9 ;;^UTILITY(U,$J,358.3,48153,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,48153,1,3,0)
+12 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Right Eye
+13 ;;^UTILITY(U,$J,358.3,48153,1,4,0)
+14 ;;=4^E11.3411
+15 ;;^UTILITY(U,$J,358.3,48153,2)
+16 ;;=^5138347
+17 ;;^UTILITY(U,$J,358.3,48154,0)
+18 ;;=E11.3412^^185^2417^44
+19 ;;^UTILITY(U,$J,358.3,48154,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,48154,1,3,0)
+22 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Left Eye
+23 ;;^UTILITY(U,$J,358.3,48154,1,4,0)
+24 ;;=4^E11.3412
+25 ;;^UTILITY(U,$J,358.3,48154,2)
+26 ;;=^5138348
+27 ;;^UTILITY(U,$J,358.3,48155,0)
+28 ;;=E11.3413^^185^2417^45
+29 ;;^UTILITY(U,$J,358.3,48155,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,48155,1,3,0)
+32 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/ Macular Edema,Bilaterral
+33 ;;^UTILITY(U,$J,358.3,48155,1,4,0)
+34 ;;=4^E11.3413
+35 ;;^UTILITY(U,$J,358.3,48155,2)
+36 ;;=^5138349
+37 ;;^UTILITY(U,$J,358.3,48156,0)
+38 ;;=E11.3491^^185^2417^46
+39 ;;^UTILITY(U,$J,358.3,48156,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,48156,1,3,0)
+42 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Right Eye
+43 ;;^UTILITY(U,$J,358.3,48156,1,4,0)
+44 ;;=4^E11.3491
+45 ;;^UTILITY(U,$J,358.3,48156,2)
+46 ;;=^5138351
+47 ;;^UTILITY(U,$J,358.3,48157,0)
+48 ;;=E11.3492^^185^2417^47
+49 ;;^UTILITY(U,$J,358.3,48157,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,48157,1,3,0)
+52 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Left Eye
+53 ;;^UTILITY(U,$J,358.3,48157,1,4,0)
+54 ;;=4^E11.3492
+55 ;;^UTILITY(U,$J,358.3,48157,2)
+56 ;;=^5138352
+57 ;;^UTILITY(U,$J,358.3,48158,0)
+58 ;;=E11.3493^^185^2417^48
+59 ;;^UTILITY(U,$J,358.3,48158,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,48158,1,3,0)
+62 ;;=3^Diabetes Type 2 w/ Severe Nonp Rtnop w/o Macular Edema,Bilateral
+63 ;;^UTILITY(U,$J,358.3,48158,1,4,0)
+64 ;;=4^E11.3493
+65 ;;^UTILITY(U,$J,358.3,48158,2)
+66 ;;=^5138353
+67 ;;^UTILITY(U,$J,358.3,48159,0)
+68 ;;=E11.3511^^185^2417^37
+69 ;;^UTILITY(U,$J,358.3,48159,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,48159,1,3,0)
+72 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Right Eye
+73 ;;^UTILITY(U,$J,358.3,48159,1,4,0)
+74 ;;=4^E11.3511
+75 ;;^UTILITY(U,$J,358.3,48159,2)
+76 ;;=^5138355
+77 ;;^UTILITY(U,$J,358.3,48160,0)
+78 ;;=E11.3512^^185^2417^38
+79 ;;^UTILITY(U,$J,358.3,48160,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,48160,1,3,0)
+82 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Left Eye
+83 ;;^UTILITY(U,$J,358.3,48160,1,4,0)
+84 ;;=4^E11.3512
+85 ;;^UTILITY(U,$J,358.3,48160,2)
+86 ;;=^5138356
+87 ;;^UTILITY(U,$J,358.3,48161,0)
+88 ;;=E11.3513^^185^2417^39
+89 ;;^UTILITY(U,$J,358.3,48161,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,48161,1,3,0)
+92 ;;=3^Diabetes Type 2 w/ Prolif Rtnop w/ Macular Edema,Bilateral
+93 ;;^UTILITY(U,$J,358.3,48161,1,4,0)
+94 ;;=4^E11.3513
+95 ;;^UTILITY(U,$J,358.3,48161,2)
+96 ;;=^5138357
+97 ;;^UTILITY(U,$J,358.3,48162,0)
+98 ;;=E11.3551^^185^2417^50
+99 ;;^UTILITY(U,$J,358.3,48162,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,48162,1,3,0)
+102 ;;=3^Diabetes Type 2 w/ Stable Prolif Rtnop,Right Eye
+103 ;;^UTILITY(U,$J,358.3,48162,1,4,0)
+104 ;;=4^E11.3551
+105 ;;^UTILITY(U,$J,358.3,48162,2)
+106 ;;=^5138371
+107 ;;^UTILITY(U,$J,358.3,48163,0)
+108 ;;=E11.3552^^185^2417^51
+109 ;;^UTILITY(U,$J,358.3,48163,1,0)
+110 ;;=^358.31IA^4^2
